Pre-market Hot Trades in US Stocks
ASML pre-market down 4.08%. Based on recent key news:
<ol>
<li>
On May 13, TSMC's plans to expand its wafer fab and advanced packaging lines directly drove equipment demand, boosting ASML's order growth. TSMC's expansion requires a large number of EUV lithography machines and other equipment, creating a catalytic effect for substantial order growth. Source: Zhitong Finance
</li>
<li>
On May 12, Intel reached a foundry agreement with Apple, which is expected to significantly drive demand for semiconductor manufacturing and packaging equipment. ASML, as the world's only EUV equipment supplier, will benefit from Intel's equipment procurement. Source: Wall Street Insights
</li>
<li>
On May 13, analysts pointed out that ASML's export restrictions have been incorporated into guidance, reducing downside risks. Samsung's advanced process layout is also seen as a positive factor. Source: Jinshi Data Semiconductor equipment demand structurally expands, risks need attention.
</li>
</ol>
Corning pre-market down 4.00%. Based on recent key news:
<ol>
<li>
On May 12, Corning was repositioned as an AI infrastructure supplier, with optical communications business revenue surging 36% year-on-year, demonstrating substantial fulfillment of AI infrastructure demand, driving stock price up.
</li>
<li>
On May 12, Corning executives sold company stock, which may raise market concerns about internal confidence, leading to stock price fluctuations.
</li>
<li>
On May 12, analysts raised Corning's target price to $220, maintaining a positive outlook rating, boosting market confidence. Strong demand in the optical communications industry, with AI infrastructure driving growth.
</li>
</ol>
Top Gainers in Pre-market US Stocks
HCW Biologics pre-market up 133.53%. Based on recent key news:
<ol>
<li>
On May 14, HCW Biologics announced its Q1 2026 financial report, showing significant progress in the field of innovative integrated immunotherapy, driving stock price up. The company reported earnings per share of $0.37, exceeding market expectations, further enhancing investor confidence.
</li>
<li>
On May 14, HCW Biologics discovered in IND-enabled research that its drug HCW11-040 can prevent bronchopulmonary dysplasia (BPD), providing a positive outlook for the company's future R&amp;D and stimulating a substantial rise in stock price.
</li>
<li>
On May 15, analysts gave HCW Biologics a &#34;Buy&#34; rating, with Wall Street's 12-month price target at $2.00, which is 472.4% higher than the closing price of $0.35 on May 13, further driving the stock price up due to this optimistic market expectation. The biotechnology sector has performed strongly recently, with significant capital inflow.
</li>
</ol>
Dreamland pre-market up 93.75%. Based on recent key news:
<ol>
<li>
On May 12, Dreamland signed a memorandum of understanding with LinkFung Innovation to develop an AI-driven smart image library platform. This move is seen as a strategic step to enhance the company's market competitiveness, driving stock price up
</li>
<li>
On May 13, Dreamland's stock price surged by 126.92%, with a trading volume of approximately $219 million, indicating an extremely rare influx of capital. Technical indicators show bullish signals, but a more comprehensive analysis is needed, as market sentiment is clearly driving the movement.
</li>
<li>
On May 14, technical analysis indicated that Dreamland's stock price far exceeded key moving averages, with an RSI of 97.75, suggesting that the stock is extremely overbought and carries a significant risk of sharp correction. There have been no major positive developments in the film and entertainment industry recently.
</li>
</ol>
Auddia rose 63.85% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 15, Auddia submitted an S-4 filing to merge with Thramann Holdings, establishing McCarthy Finney as a unified AI platform. This move is seen as an important step in the company's strategic expansion, driving a significant increase in stock price. Source: Reuters
</li>
<li>
On May 12, Auddia's directors and executives participated in a proxy solicitation, with information related to the merger transaction to be disclosed in SEC filings. This information has increased market confidence in the success of the merger, further stimulating the rise in stock price. Source: Public Technologies
</li>
<li>
On May 15, investor relations documents revealed that Auddia's executives and directors hold direct and indirect interests in the merger transaction, enhancing market optimism regarding the company's future development. Source: Auddia Inc
</li>
</ol>

ASML

ASML pre-market down 4.08%; Corning pre-market down 4.00%; HCW Biologics pre-market up 133.53%; Dreamland pre-market up 93.75%; Auddia pre-market up 63.85%

Price Alert

Pre-market hot trades in US stocks: ASML down 4.08% pre-market; Corning down 4.00% pre-market